Average Co-Inventor Count = 5.56
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Shy Therapeutics LLC (12 from 12 patents)
2. Naturon Limited (4 from 5 patents)
3. Other (1 from 832,680 patents)
17 patents:
1. 12459951 - Compounds that interact with RAS superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
2. 12391705 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
3. 12168668 - Compounds for the treatment of cancer and inflammatory disease
4. 11560390 - Compounds for the treatment of cancer and inflammatory disease
5. 11541041 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease
6. 11213515 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
7. 11026930 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
8. 11000515 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
9. 10940139 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
10. 10933054 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
11. 10870657 - Compounds for the treatment of cancer and inflammatory disease
12. 10588894 - Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
13. 10370335 - Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
14. 10221191 - Compounds for the treatment of cancer and inflammatory disease
15. 8697674 - Xanthurenic acid derivative pharmaceutical compositions and methods related thereto